{"title":"Bee venom modulates human neutrophil inflammatory functions in Vitro and exerts an anti- inflammatory effect in Vivo in rats.","authors":"Meriem-Dehbia Chabane, Samia Bedouhene, Sahra-Amel Belambri, Nassima Senani, Tinhinane Rekeb, Kahina Ladj, Riadh Ksouri, Pham My-Chan Dang, Jamel El-Benna","doi":"10.1007/s10787-025-01797-9","DOIUrl":null,"url":null,"abstract":"<p><p>Bee venom (BV) is a complex bioactive mixture known for its paradoxical ability to exert both pro-inflammatory and anti-inflammatory effects, making it a compelling modulator of inflammatory responses. In this study, we investigated the effect of BV on human neutrophil inflammatory functions in vitro and its effect on inflammation in vivo in rats. Results revealed that BV exhibited a dose-dependent inhibitory effect on formyl-Met-Leu-Phe (fMLF)-induced superoxide production by neutrophils, without affecting PMA-induced superoxide production or superoxide production by the xanthine-xanthine oxidase system. BV was not toxic to neutrophils and did not affect neutrophil adhesion, however, and surprisingly it induced myeloperoxidase release from neutrophils. Interestingly, in vivo BV effectively suppressed xylene-induced ear edema and significantly reduced carrageenan-induced peritonitis by limiting neutrophil recruitment to the peritoneum. These findings suggest that although bee venom can either inhibit or stimulate neutrophil functions in vitro, it still exerts an anti-inflammatory effect in vivo. This dual action highlights the complexity of BV's bioactive components and the importance of targeted therapeutic modulation in inflammatory conditions.</p>","PeriodicalId":13551,"journal":{"name":"Inflammopharmacology","volume":" ","pages":""},"PeriodicalIF":5.3000,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Inflammopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10787-025-01797-9","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Bee venom (BV) is a complex bioactive mixture known for its paradoxical ability to exert both pro-inflammatory and anti-inflammatory effects, making it a compelling modulator of inflammatory responses. In this study, we investigated the effect of BV on human neutrophil inflammatory functions in vitro and its effect on inflammation in vivo in rats. Results revealed that BV exhibited a dose-dependent inhibitory effect on formyl-Met-Leu-Phe (fMLF)-induced superoxide production by neutrophils, without affecting PMA-induced superoxide production or superoxide production by the xanthine-xanthine oxidase system. BV was not toxic to neutrophils and did not affect neutrophil adhesion, however, and surprisingly it induced myeloperoxidase release from neutrophils. Interestingly, in vivo BV effectively suppressed xylene-induced ear edema and significantly reduced carrageenan-induced peritonitis by limiting neutrophil recruitment to the peritoneum. These findings suggest that although bee venom can either inhibit or stimulate neutrophil functions in vitro, it still exerts an anti-inflammatory effect in vivo. This dual action highlights the complexity of BV's bioactive components and the importance of targeted therapeutic modulation in inflammatory conditions.
期刊介绍:
Inflammopharmacology is the official publication of the Gastrointestinal Section of the International Union of Basic and Clinical Pharmacology (IUPHAR) and the Hungarian Experimental and Clinical Pharmacology Society (HECPS). Inflammopharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. The comparative aspects of the types of inflammatory conditions include gastrointestinal disease (e.g. ulcerative colitis, Crohn''s disease), parasitic diseases, toxicological manifestations of the effects of drugs and environmental agents, arthritic conditions, and inflammatory effects of injury or aging on skeletal muscle. The journal has seven main interest areas:
-Drug-Disease Interactions - Conditional Pharmacology - i.e. where the condition (disease or stress state) influences the therapeutic response and side (adverse) effects from anti-inflammatory drugs. Mechanisms of drug-disease and drug disease interactions and the role of different stress states
-Rheumatology - particular emphasis on methods of measurement of clinical response effects of new agents, adverse effects from anti-rheumatic drugs
-Gastroenterology - with particular emphasis on animal and human models, mechanisms of mucosal inflammation and ulceration and effects of novel and established anti-ulcer, anti-inflammatory agents, or antiparasitic agents
-Neuro-Inflammation and Pain - model systems, pharmacology of new analgesic agents and mechanisms of neuro-inflammation and pain
-Novel drugs, natural products and nutraceuticals - and their effects on inflammatory processes, especially where there are indications of novel modes action compared with conventional drugs e.g. NSAIDs
-Muscle-immune interactions during inflammation [...]